by admin | Nov 22, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Frank Vinluan – MedCity News – Autolus Therapeutics’ Aucatzyl is now FDA approved for treating advanced cases of B-cell precursor acute lymphoblastic leukemia. While it goes after the same target as Gilead Sciences’ Tecartus, Autolus engineered its CAR...
by admin | Nov 21, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Smriti Mallapaty – Nature – The treatment, given to four people with damaged corneas, seems safe but needs to be tested in larger trials. Three people with severely impaired vision who received stem-cell transplants have experienced substantial...
by admin | Nov 20, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By By Jordana Lenon – University of Wisconsin-Madison – Heart muscle cells grown from stem cells show promise in monkeys with a heart problem that typically results from a heart defect sometimes present at birth in humans, according to new research from...
by admin | Nov 19, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Christiane Klasen – Phys.org – Human induced pluripotent stem cells (iPSCs) have a great potential for scientific and medical applications. They are used in research laboratories to model human diseases, helping to uncover underlying mechanisms and...
by admin | Nov 18, 2024 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Texas A&M College of Medicine News – A new therapy may delay Alzheimer’s disease progression by years, according to a study by researchers at Texas A&M University College of Medicine. Published in the Journal of Extracellular Vesicles, the research...
